BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 19339940)

  • 1. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccines in HIV-positive men and women.
    De Vuyst H; Franceschi S
    Curr Opin Oncol; 2007 Sep; 19(5):470-5. PubMed ID: 17762573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.
    Tong WW; Hillman RJ; Kelleher AD; Grulich AE; Carr A
    HIV Med; 2014 Feb; 15(2):65-76. PubMed ID: 24007498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention, chemoradiation and surgery for anal cancer.
    Buchs NC; Allal AS; Morel P; Gervaz P
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):483-9. PubMed ID: 19374601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
    Palefsky JM
    Semin Oncol; 2000 Aug; 27(4):471-9. PubMed ID: 10950374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model].
    Monsonego J
    Gynecol Obstet Fertil; 2010 Apr; 38(4):250-4. PubMed ID: 20362481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
    Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
    Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing an anal dysplasia clinic for HIV-infected men: initial experience.
    Siekas LL; Aboulafia DM
    AIDS Read; 2009 May; 19(5):178-86. PubMed ID: 19554736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
    Deshmukh AA; Chhatwal J; Chiao EY; Nyitray AG; Das P; Cantor SB
    Clin Infect Dis; 2015 Nov; 61(10):1527-35. PubMed ID: 26223993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus-related tumors in HIV.
    Palefsky J
    Curr Opin Oncol; 2006 Sep; 18(5):463-8. PubMed ID: 16894294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
    Swedish KA; Factor SH; Goldstone SE
    Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV.
    de Pokomandy A; Rouleau D; Ghattas G; Trottier H; Vézina S; Coté P; Macleod J; Allaire G; Hadjeres R; Franco EL; Coutlée F
    Clin Infect Dis; 2011 May; 52(9):1174-81. PubMed ID: 21364075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus, cancer and vaccination.
    Heard I
    Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals.
    Palefsky JM; Berry JM; Jay N; Krogstad M; Da Costa M; Darragh TM; Lee JY
    AIDS; 2006 May; 20(8):1151-5. PubMed ID: 16691066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus-related disease in people with HIV.
    Palefsky J
    Curr Opin HIV AIDS; 2009 Jan; 4(1):52-6. PubMed ID: 19339939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.